News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer’s disease
Wednesday, July 20, 2022Roche has announced that the US Food and Drug Administration FDA has granted Breakthrough Device Designation to the Elecsys Amyloid Plasma Panel an innovative solution designed to enable early detection of Alzheimers disease The Elecsys Amyloid Plasm...
ORYZON enters cooperative research and development agreement (CRADA) with U.S. National Cancer Institute to develop iadademstat in different cancers
Wednesday, July 20, 2022Oryzon Genomics SA a biopharmaceutical company focused on leveraging epigenetics to develop therapies for diseases with significant unmet medical needs announced today the establishment of a Cooperative Research and Development Agreement CRADA with t...
Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology
Tuesday, July 19, 2022Carl Zeiss Meditec Precise Bio partnership fabricated corneal tissue transplants endothelial keratoplasty natural lenticule transplants keratoconus vision correction investment funding cornea transplant products worldwide commercialization rights
Astorg Completes Acquisition of OPEN Health From Amulet Capital Partners
Tuesday, July 19, 2022Astorg and Amulet Capital Partners have finalized the acquisition of OPEN Health a global provider of scientific communications and market access services to the pharmaceutical industry OPEN Health established in operates in locations across six co...
Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab
Friday, July 15, 2022Polpharma Biologics an international biotech company specializing in biosimilar development announced today that the European Medicines Agency EMA has officially accepted the Marketing Authorization Application MAA for biosimilar natalizumab which ai...
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Thursday, July 14, 2022Relief Therapeutics Holding SA a biopharmaceutical company seeking to serve patients with rare metabolic and genetic diseases with unmet medical need today announced that its wholly owned subsidiary APR Applied Pharma Research SA APR has executed a d...
Nanoform and Pharmanovia to breathe new life into iconic medicines
Thursday, July 14, 2022Nanoform Finland Plc an innovative company specializing in nanoparticle medicine technology has announced a strategic partnership with Pharmanovia a rapidly expanding specialty pharmaceutical company with a portfolio of over branded drugs available...
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
Wednesday, July 13, 2022Provepharm a French company specialized in the development of pharmaceutical applications today announces that it has received FDA New Drug Approval for the marketing of BLUDIGO its indigo carmine injectable Indigotindisulfonate Sodium drug product B...
Saphetor Partners With PTC Therapeutics to Advance Awareness of Clinical Programs in Rare Diseases
Wednesday, July 13, 2022Saphetor a global precision medicine company and the creator of VarSome The Human Genomics Community and variant interpretation platform announced today a partnership with PTC Therapeutics International Limited The open genomics community VarSomecom...
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
Tuesday, July 12, 2022At the Euromar Conference Bruker announced three new customer orders for GHz systems which will incorporate novel compact GHz NMR magnets for structural biology applications and clinical research in singlestory laboratories The new Ascend Evo GHz...
